BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 8127953)

  • 1. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
    Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
    Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
    Wakabayashi T; Kato H; Ikeda T; Schull WJ
    Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risks and biomarker studies in the atomic bomb survivors.
    Preston D
    Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001.
    Hsu WL; Preston DL; Soda M; Sugiyama H; Funamoto S; Kodama K; Kimura A; Kamada N; Dohy H; Tomonaga M; Iwanaga M; Miyazaki Y; Cullings HM; Suyama A; Ozasa K; Shore RE; Mabuchi K
    Radiat Res; 2013 Mar; 179(3):361-82. PubMed ID: 23398354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis.
    Little MP; Weiss HA; Boice JD; Darby SC; Day NE; Muirhead CR
    Radiat Res; 1999 Sep; 152(3):280-92. PubMed ID: 10453089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks.
    Little MP; Hawkins MM; Charles MW; Hildreth NG
    Radiat Res; 1992 Nov; 132(2):207-21. PubMed ID: 1438703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
    Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE
    Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
    Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
    J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis.
    Kai M; Luebeck EG; Moolgavkar SH
    Radiat Res; 1997 Oct; 148(4):348-58. PubMed ID: 9339951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male breast cancer incidence among atomic bomb survivors.
    Ron E; Ikeda T; Preston DL; Tokuoka S
    J Natl Cancer Inst; 2005 Apr; 97(8):603-5. PubMed ID: 15840883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ
    Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982.
    Preston DL; Kato H; Kopecky K; Fujita S
    Radiat Res; 1987 Jul; 111(1):151-78. PubMed ID: 3446217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cancer mortality among atomic bomb survivors in Hiroshima Prefecture, 1968-1997.
    Zhunussova T; Matsuura M; Hayakawa N
    Hiroshima J Med Sci; 2003 Mar; 52(1):1-7. PubMed ID: 12701647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.